Age‐stratified analysis showed that KIBRA PM conferred a significantly increased the risk of GC in the older group (≥ 60 years, ORa = 1.846, 95% CI: 1.037–3.287, P = 0.037), while no significant difference was detected in the younger group (< 60 years). This evidence concerns the gene WWC1 and gastric cancer.